Cinapen

There is no image.

Escitalopram

Method of action: Antidepressant, Blocking The Reuptake Of Serotonin, Psychoanaleptics

Treatment option: Agoraphobia, Generalized Anxiety Disorder, Depression, Obsessive Compulsive Disorder, Obsessive Compulsive Personality Disorder, Panic, Anxiety&Panic Attacks, Panic Attacks And Panic Disorder, Phobia, Phobia,Social

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cinapen

Quick Facts

Property	Description
Active ingredient	Escitalopram (as oxalate salt)
Form	Tablet, Oral solution
Pharmacological class	Selective Serotonin Reuptake Inhibitor (SSRI)
General purpose	Supports mood regulation and emotional balance
Origin	Synthetic compound

What Type of Medicine is Cinapen? (Identity and Classification)

Cinapen is a prescription-only synthetic medicine whose active ingredient is Escitalopram, formally classified as a Selective Serotonin Reuptake Inhibitor (SSRI). This classification places it within the group of antidepressants known for their high specificity in the central nervous system. The medication is commonly applied in scenarios where patients experience difficulties in maintaining sustained, positive emotional stability. As an SSRI, Escitalopram is characterized by its targeted ability to modulate the neurochemical environment, helping the brain achieve a more stable chemical state essential for mental function.

Escitalopram: The Active Ingredient and Chemical Origin

The sole active ingredient in Cinapen is Escitalopram, typically administered as the oxalate salt for oral consumption. The compound itself is a bicyclic phthalane derivative, meaning its origin is entirely synthetic. Its primary physiological action involves inhibiting the neuronal reuptake of the neurotransmitter serotonin (5-HT). Escitalopram possesses a key differentiating feature: it is the purified S-enantiomer of Citalopram, distinguishing it as a highly selective, single-isomer compound. This increase in serotonin activity is the mechanism by which the medication helps correct chemical imbalances associated with certain mental health conditions.

What are the Available Forms of Cinapen?

Cinapen is designed for oral administration and is commercially available as both a solid tablet and a liquid oral solution. Both preparations contain the same active agent, Escitalopram, ensuring consistent systemic delivery of the medication. The availability of these two distinct forms provides flexibility for use, particularly for patients who may require an alternative to solid forms, or who need to adjust doses incrementally under medical supervision. The established oral route is necessary for the systemic absorption of the compound required for its therapeutic effect.

Regulatory References

What side effects are possible with Cinapen?

Possible Side Effects and Safety Information

The safety profile of Escitalopram (Cinapen) is defined by officially documented adverse reactions organized by frequency and the body system affected, as classified in government regulatory documents.

Adverse reactions are most frequently reported during the first or second week of treatment and often lessen with continued use. Monitoring is explicitly required during initial therapy and at times of dosage changes, particularly for clinical worsening and the emergence of suicidal ideation and behavior, especially in young adults (up to age 24).

Official Frequency Classification (Selected)

Classification	Examples of Documented Effects
Very Common (≥ 1/10)	Headache, Nausea
Common (≥ 1/100 to < 1/10)	Insomnia, Somnolence, Diarrhoea, Dry mouth, Fatigue, Sexual dysfunction (e.g., decreased libido)
Rare (< 1/1,000)	Serotonin Syndrome, Anaphylactic reaction, Aggression
Not Known	QT interval prolongation, Torsade de pointes, Hyponatraemia

Serious Adverse Reactions and Safety Constraints

Regulatory documents list serious adverse reactions that require specific caution. These include the documented risk of Serotonin Syndrome, QT interval prolongation (a cardiac rhythm change), and an increased risk of Abnormal Bleeding events. Hyponatraemia (low blood sodium) is a documented concern, with older adults potentially being at higher risk. The medicine is generally not recommended for use in individuals with severe hepatic impairment. Caution is advised when prescribing to patients with a history of seizures or conditions that increase the risk of Angle-Closure Glaucoma.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Cinapen is a serious medical emergency, with a risk of outcomes that are life-threatening or fatal. The critical dangers are profound sedation, coma, and severe respiratory depression (dangerously slowed or stopped breathing) resulting from central nervous system (CNS) effects. A rare but serious brain condition, toxic leukoencephalopathy, has been documented following overdose.

When to Seek Immediate Medical Help

Immediate emergency medical attention (Call 911 or local emergency services) is required if a person shows any of the following symptoms, as they indicate a potentially fatal overdose:

Symptom Cluster	Description (Official Regulatory Basis)
Respiratory Depression	Slowed, shallow, or absent breathing.
CNS Depression	Inability to wake up or unresponsiveness (coma), profound or extreme sleepiness.
Circulatory Signs	Cold, clammy skin and pale or bluish lips or fingernails.
Pupil Size	Very small, constricted pupils (pinpoint pupils).

Overdose Risk Factors

Anyone using Cinapen may be at risk for overdose, but the risk is significantly higher under certain conditions:

Accidental Ingestion: Accidental intake of even one dose, especially by a child, can result in a fatal overdose.
Drug Combinations: Using Cinapen concurrently with other CNS depressants, including alcohol, benzodiazepines, or other sedating medicines, substantially increases the risk of serious respiratory depression, coma, and death.
Dosage: The risk of overdose is increased with higher doses of the medication.

If an overdose is suspected, an opioid reversal agent (e.g., naloxone) should be administered if available, and emergency services must be called immediately, even if the individual temporarily improves after naloxone is given.

Therapeutic Uses of Cinapen

Cinapen is commonly used across domains where additional symptomatic support is needed, such as in chronic and episodic mental health conditions. The medication is relevant for managing symptoms that interfere with routine activities and may assist with maintaining functional stability.

The core therapeutic domains include Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), Panic Disorder (PD), Social Anxiety Disorder (SAD), and Obsessive-Compulsive Disorder (OCD). Its use may assist with contributing to easing the overall symptom load when symptoms create noticeable physiological strain.

“It is applied when symptoms escalate temporarily and supportive relief is needed.”

Cinapen is applied in addressing symptom clusters such as persistent low mood and anhedonia, excessive worry and restlessness, and the challenging manifestations of recurrent, unwanted obsessions and panic attacks. It may assist with maintaining functional stability and supports general well-being during symptomatic phases by easing discomfort associated with symptom fluctuations.

Quick Fact: Supportive Management for Key Symptoms
Low Mood and Sadness	Supports patients during difficult episodes.
Excessive Worry	Is applied in addressing chronic apprehension and restlessness.
Panic Attacks	Is relevant for managing sudden, intense fear episodes.
Intrusive Thoughts	May assist with addressing obsessive manifestations.

Regulatory References

U.S. National Library of Medicine (MedlinePlus) Drug Information

Eligibility and Restrictions for Use

Cinapen's official eligibility profile is strictly defined by regulatory authorities based on population safety, age, and organ function.

Absolute Contraindications

Use of Cinapen is strictly prohibited for patients with known hypersensitivity to escitalopram, citalopram, or any component of the formulation. It is also contraindicated when co-administered with Monoamine Oxidase Inhibitors (MAOIs), including Linezolid and Intravenous Methylene Blue, and with the antipsychotic medicine Pimozide.

Age-Related and Conditional Use

Population Group	Eligibility Status (According to Official Labeling)
Adults (MDD/GAD)	Approved for use.
Adolescents (MDD)	Approved for patients mathbf12 years and older.
Children (GAD)	Approved for patients mathbf7 years and older.
Older Adults (mathbfge 65 years)	Typically advised a lower maximum daily dose due to altered drug clearance.

️ Use Restrictions and Cautions

Conditional use is required in specific populations. Patients with severe hepatic impairment (liver function) or severe renal impairment should only use Cinapen with caution and may require a dose limitation. Official labeling also advises caution and monitoring for individuals with a history of seizures or mania/hypomania, as these conditions may be affected. Use during pregnancy is advised only if the benefit is determined to justify the potential risk to the fetus.

What should I know about interactions with other medicines?

Cinapen (Escitalopram) has specific interaction patterns documented in official regulatory labeling, defining combinations that are prohibited or require careful consideration based on pharmacokinetic (PK) and pharmacodynamic (PD) effects.

Official Interaction Restrictions

Classification	Interacting Agents	Regulatory Constraint	Timing Rule
Contraindicated	Monoamine Oxidase Inhibitors (MAOIs), Pimozide, QTc Prolonging Agents	Prohibited co-administration due to risk of Serotonin Syndrome or cardiac events.	Mandatory 14-day washout when switching to/from psychiatric MAOIs.
Significant Risk	Other Serotonergic Agents (e.g., Triptans, Tramadol, Lithium), Drugs Affecting Hemostasis (e.g., Warfarin, NSAIDs)	Increased risk of Serotonin Syndrome (PD effect). Increased risk of abnormal bleeding (PD effect on platelet function).	N/A

Pharmacokinetic Interactions

Cinapen is documented to be metabolized by CYP2C19 and CYP3A4 and is classified as an inhibitor of CYP2D6. Co-administration with drugs that inhibit CYP2C19 or CYP3A4 (e.g., Cimetidine, Ketoconazole) may result in an increase in Cinapen’s plasma concentration. Conversely, Cinapen may increase the exposure of certain drugs metabolized by CYP2D6 (e.g., Metoprolol).

Mechanism of Action

Cinapen functions as a selective synthetic non-steroidal inhibitor that targets the enzyme Farnesyl Pyrophosphate Synthase (FPPS). This enzyme is a pivotal component of the mevalonate pathway, which is responsible for the synthesis of isoprenoid lipids, specifically farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP).

By inhibiting FPPS activity, Cinapen disrupts the production of FPP and GGPP. These isoprenoid lipids are required for the prenylation of small signaling molecules, including numerous small GTPases (such as Rho, Rac, and Ras). Prenylation is a post-translational modification essential for anchoring these GTPases to the inner surface of the cell membrane, which is necessary for their activation and signal transduction. The subsequent disruption of this membrane association leads to the inactivation of the GTPases.

The inhibition of this intracellular signaling cascade culminates in a system-level physiological consequence within osteoclasts. The inactivation of the Rho/Rac/Ras axis impairs the assembly and function of the osteoclast cytoskeleton, preventing the formation of the ruffled border. This action directly modulates bone turnover dynamics through the reduction of cell-mediated bone resorption.

Dosage and Administration Information

How Cinapen is Used: Administration Overview

Cinapen (Escitalopram) is administered according to established protocols. These parameters define the clinical use of the compound.

Administration and Dosing

Cinapen is intended for oral administration and is available as a tablet (5 mg, 10 mg, 20 mg) and a liquid oral solution (1 mg/mL). It is typically taken once daily and may be consumed with or without food.

Regimen Detail	Standard Adult Instruction (MDD/GAD)
Starting Dose	10 mg once daily
Maximum Dose	20 mg once daily
Dose Increase	Not sooner than one week after starting treatment

Use Over Time and Special Instructions

Treatment duration often extends for at least six months following symptom resolution to maintain stability. The liquid solution requires a measured device for accurate dosing. The 10 mg and 20 mg tablets are scored and can be divided.

Specific Population Rules: The maximum recommended dose for older adults (65 years) and those with hepatic impairment is generally limited to 10 mg once daily. When discontinuing Cinapen, the dosage is gradually reduced (tapered) over at least one to two weeks to minimize discontinuation effects.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Cinapen (Escitalopram)

Evidence for use in Major Depressive Disorder (MDD)

The research foundation for Cinapen was studied for Major Depressive Disorder primarily relies on short-term, randomized controlled trials (RCTs) against placebo (an inactive substance). These studies typically last for 6 to 8 weeks. Researchers focus on observing how symptoms change over time by using standardized, clinician-rated scales like the MADRS and the HDRS. The main goal of this research is to measure and describe changes in core symptoms, as well as the proportion of patients who reach certain defined thresholds for improvement.

Cinapen was also studied for adolescents (patients aged 12 to 17 years) diagnosed with MDD, using similar short-term RCT designs. Findings from a combination of trials and reviews describe patterns of change in symptom scores in the populations studied over these defined time intervals.

Evidence for use in Generalized Anxiety Disorder (GAD)

The evidence evaluated for Generalized Anxiety Disorder (GAD) largely derives from placebo-controlled RCTs. These studies were used in research exploring how GAD symptoms change over time, specifically measuring excessive worry and physical discomfort associated with anxiety using scales like the Hamilton Anxiety Rating Scale (HAM-A). The populations studied included adults with GAD, as well as children and adolescents with the condition.

Findings from these short-term trials (often lasting 8 weeks) report measurements of changes in anxiety scores in the groups studied, compared to those receiving placebo. Research also reports on the proportion of patients who achieved a specified level of improvement during the observed period.

Evidence for use in Panic Disorder (PD) and Social Anxiety Disorder (SAD)

Cinapen was studied for conditions characterized by fluctuating manifestations, such as Panic Disorder (PD) and Social Anxiety Disorder (SAD). The research involves placebo-controlled RCTs and relapse prevention studies focused on outcomes related to episodic changes. For PD, studies recorded the frequency and severity of panic attacks, while SAD research explored symptoms of social avoidance in social situations. Studies report how symptoms evolved in the observed populations, and findings indicate patterns related to changes related to the frequency and severity of episodes in the groups studied over defined time intervals.

Frequently Asked Questions (FAQ)

Common questions about Cinapen (FAQ)

Q: What is the main active ingredient in Cinapen?

Cinapen contains Amoxicillin trihydrate, which is classified as the main active pharmaceutical ingredient. Amoxicillin is a type of penicillin antibiotic that is used to treat infections caused by specific bacteria. This composition information is consistently described in the regulatory documents for the product.

Q: Does Cinapen treat viral infections, like the common cold?

According to the official product information, Cinapen is an antibiotic and is specifically indicated only for infections caused by bacteria. It is not effective against viral illnesses, such as the common cold or flu. Regulatory warnings emphasize that antibiotics, including Cinapen, should only be used for bacterial infections to help manage the risk of developing resistance.

Q: What types of infections is Cinapen typically prescribed for?

Regulatory documents state that Cinapen is used for treating various bacterial infections. These may include specific infections affecting the ear, nose, throat, skin, and urinary tract, depending on the bacteria involved. Prescribing information indicates that a healthcare professional assesses the appropriateness of Cinapen based on the specific type of bacterial infection.

Q: How long does it usually take for Cinapen to start working?

Official documentation suggests that signs of improvement may be observed within a few days of starting the medication. However, the full course of treatment must be completed to ensure the infection is fully cleared. Patients are generally advised to complete the full course of therapy as directed by the prescriber, even if symptoms subside.

Q: Is it safe to drink alcohol while taking Cinapen?

According to the official product information, there is no specific major interaction listed between Cinapen (amoxicillin) and alcohol. However, alcohol consumption may sometimes worsen general side effects or symptoms associated with being ill. Patients who wish to consume alcohol should discuss their overall treatment plan with a healthcare provider.

Q: Can Cinapen be taken with food?

Official product information states that Cinapen can be taken either with or without food. Taking it with food may sometimes help reduce the chance of mild stomach upset in some individuals. Adherence to the specific guidance provided by a healthcare professional is recommended.

Q: What should I do if I miss a dose of Cinapen?

Official product labeling provides instructions for managing a missed dose, typically advising patients to avoid taking two doses close together. The goal is to return to the regular dosing schedule as soon as possible without doubling up. Specific guidance on missed doses should always be confirmed with the prescriber or pharmacist.

How should Cinapen be stored and disposed of?

How to Store and Dispose of Cinapen (Escitalopram)

Cinapen must be stored and disposed of according to strict official labeling to maintain its stability and safety.

Official Storage Requirements

The medicine should be stored at Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F). Storage conditions require protection from freezing, excessive heat, moisture, and direct light. Both tablets and oral solution must be kept in their original container with the cap tightly closed.

Oral Solution Stability: The Escitalopram oral solution must be discarded 2 months after the bottle is first opened.
Child Safety: Cinapen must be stored out of the reach of children.

Disposal Instructions

Unused or expired Cinapen should be disposed of in accordance with local regulations, often via an authorized drug take-back program. The product must not be flushed down a toilet or poured down a sink to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.